BioN­Tech wait­ed to col­lect its $100M PRV un­til just be­fore Mod­er­na's Covid-19 vac­cine ap­proval

The FDA on Fri­day re­leased a new let­ter sent last week to BioN­Tech and Pfiz­er re­gard­ing their qui­et­ly held pri­or­i­ty re­view vouch­er. De­spite the fact that the com­pa­ny could’ve col­lect­ed the vouch­er af­ter win­ning ap­proval for their Covid-19 vac­cine in Au­gust, the let­ter was re­leased just a day af­ter BioN­Tech’s SEC fil­ing of an End­points News sto­ry yes­ter­day re­veal­ing the ex­is­tence of the $100+ mil­lion vouch­er.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER